Effect of Taurine in treatment of diabetes
Phase 3
- Conditions
- Type 2 diabetes.Type 2 diabetes mellitus
- Registration Number
- IRCT20180712040438N3
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Patients with Type 2 Diabetes Patients who use glucose lowering oral medications are well controlled by their blood glucose levels.
Body mass index 35-25 kg /m 2 will be included in the study. age range from 30-60 years
Exclusion Criteria
Use of multi-vitamin and mineral supplements over the past 3 months.
Taking corticosteroids and non-steroidal anti-inflammatory drugs.
Taking insulin Patients with polycystic ovary syndrome Patients with chronic diseases such as cardiovascular, renal and hepatic disorders, and hypothyroidism and hyperthyroidism
Having certain physiological conditions such as pregnancy and lactation.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method